Imaging of hepatocellular carcinoma response after 90y radioembolization

Sahar Semaan; Jasnit Makkar; Sara Lewis; Manjil Chatterji; Edward Kim; Bachir Taouli

doi:10.2214/AJR.17.17993

Imaging of hepatocellular carcinoma response after ⁹⁰y radioembolization

Sahar Semaan
, Jasnit Makkar
, Sara Lewis
, Manjil Chatterji
, Edward Kim
, Bachir Taouli

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

OBJECTIVE. The purpose of this study is to discuss the imaging modalities and response criteria used for assessing hepatocellular carcinoma (HCC) response to ⁹⁰Y radioembolization, as well as the imaging appearances of treated tumors. CONCLUSION. An understanding of the appearance of HCC after ⁹⁰Y radioembolization is crucial for accurate evaluation of treatment response. Residual tumor necrosis and enhancement are essential for assessing response. Multiparametric MRI, including DWI and perfusion imaging, plays an emerging role in response assessment and outcome prediction.

Original language	English
Pages (from-to)	W263-W276
Journal	American Journal of Roentgenology
Volume	209
Issue number	5
DOIs	https://doi.org/10.2214/AJR.17.17993
State	Published - Nov 2017

Keywords

Hepatocellular carcinoma
Radioembolization
Treatment response
Yttrium-

Access to Document

10.2214/AJR.17.17993

Cite this

@article{09127edf72a54d5ab6ba1363e406094f,

title = "Imaging of hepatocellular carcinoma response after 90y radioembolization",

abstract = "OBJECTIVE. The purpose of this study is to discuss the imaging modalities and response criteria used for assessing hepatocellular carcinoma (HCC) response to 90Y radioembolization, as well as the imaging appearances of treated tumors. CONCLUSION. An understanding of the appearance of HCC after 90Y radioembolization is crucial for accurate evaluation of treatment response. Residual tumor necrosis and enhancement are essential for assessing response. Multiparametric MRI, including DWI and perfusion imaging, plays an emerging role in response assessment and outcome prediction.",

keywords = "Hepatocellular carcinoma, Radioembolization, Treatment response, Yttrium-",

author = "Sahar Semaan and Jasnit Makkar and Sara Lewis and Manjil Chatterji and Edward Kim and Bachir Taouli",

note = "Publisher Copyright: {\textcopyright} 2017 American Roentgen Ray Society.",

year = "2017",

month = nov,

doi = "10.2214/AJR.17.17993",

language = "English",

volume = "209",

pages = "W263--W276",

journal = "American Journal of Roentgenology",

issn = "0361-803X",

publisher = "American Roentgen Ray Society",

number = "5",

}

TY - JOUR

T1 - Imaging of hepatocellular carcinoma response after 90y radioembolization

AU - Semaan, Sahar

AU - Makkar, Jasnit

AU - Lewis, Sara

AU - Chatterji, Manjil

AU - Kim, Edward

AU - Taouli, Bachir

PY - 2017/11

Y1 - 2017/11

N2 - OBJECTIVE. The purpose of this study is to discuss the imaging modalities and response criteria used for assessing hepatocellular carcinoma (HCC) response to 90Y radioembolization, as well as the imaging appearances of treated tumors. CONCLUSION. An understanding of the appearance of HCC after 90Y radioembolization is crucial for accurate evaluation of treatment response. Residual tumor necrosis and enhancement are essential for assessing response. Multiparametric MRI, including DWI and perfusion imaging, plays an emerging role in response assessment and outcome prediction.

AB - OBJECTIVE. The purpose of this study is to discuss the imaging modalities and response criteria used for assessing hepatocellular carcinoma (HCC) response to 90Y radioembolization, as well as the imaging appearances of treated tumors. CONCLUSION. An understanding of the appearance of HCC after 90Y radioembolization is crucial for accurate evaluation of treatment response. Residual tumor necrosis and enhancement are essential for assessing response. Multiparametric MRI, including DWI and perfusion imaging, plays an emerging role in response assessment and outcome prediction.

KW - Hepatocellular carcinoma

KW - Radioembolization

KW - Treatment response

KW - Yttrium-

UR - https://www.scopus.com/pages/publications/85032669621

U2 - 10.2214/AJR.17.17993

DO - 10.2214/AJR.17.17993

M3 - Article

C2 - 29072955

AN - SCOPUS:85032669621

SN - 0361-803X

VL - 209

SP - W263-W276

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

IS - 5